Revvity Pre-Tax Profit Margin 2012-2026 | RVTY
Current and historical pre-tax profit margin for Revvity (RVTY) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Revvity pre-tax profit margin for the three months ending June 30, 2026 was .
| Revvity Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $2.91B | $0.26B | 9.00% |
| 2026-03-31 | $2.90B | $0.27B | 9.20% |
| 2025-12-31 | $2.86B | $0.27B | 9.42% |
| 2025-09-30 | $2.81B | $0.27B | 9.67% |
| 2025-06-30 | $2.80B | $0.32B | 11.29% |
| 2025-03-31 | $2.77B | $0.33B | 12.06% |
| 2024-12-31 | $2.76B | $0.32B | 11.51% |
| 2024-09-30 | $2.72B | $0.25B | 9.29% |
| 2024-06-30 | $2.71B | $0.20B | 7.53% |
| 2024-03-31 | $2.73B | $0.19B | 6.93% |
| 2023-12-31 | $2.75B | $0.18B | 6.65% |
| 2023-09-30 | $2.80B | $0.29B | 10.37% |
| 2023-06-30 | $2.84B | $0.32B | 11.31% |
| 2023-03-31 | $3.02B | $0.46B | 15.05% |
| 2022-12-31 | $3.31B | $0.65B | 19.66% |
| 2022-09-30 | $3.00B | $0.78B | 25.82% |
| 2022-06-30 | $3.15B | $0.83B | 26.29% |
| 2022-03-31 | $3.48B | $0.95B | 27.23% |
| 2021-12-31 | $3.83B | $1.20B | 31.43% |
| 2021-09-30 | $3.63B | $1.31B | 36.01% |
| 2021-06-30 | $3.74B | $1.41B | 37.67% |
| 2021-03-31 | $3.32B | $1.25B | 37.54% |
| 2020-12-31 | $2.66B | $0.80B | 30.08% |
| 2020-09-30 | $3.23B | $0.50B | 15.43% |
| 2020-06-30 | $2.98B | $0.33B | 11.02% |
| 2020-03-31 | $2.89B | $0.24B | 8.14% |
| 2019-12-31 | $2.88B | $0.24B | 8.22% |
| 2019-09-30 | $2.84B | $0.25B | 8.85% |
| 2019-06-30 | $2.80B | $0.27B | 9.49% |
| 2019-03-31 | $2.78B | $0.27B | 9.56% |
| 2018-12-31 | $2.78B | $0.26B | 9.29% |
| 2018-09-30 | $2.66B | $0.26B | 9.76% |
| 2018-06-30 | $2.54B | $0.29B | 11.29% |
| 2018-03-31 | $2.39B | $0.29B | 11.98% |
| 2017-12-31 | $2.26B | $0.30B | 13.16% |
| 2017-09-30 | $2.18B | $0.29B | 13.06% |
| 2017-06-30 | $2.14B | $0.25B | 11.44% |
| 2017-03-31 | $2.13B | $0.24B | 11.03% |
| 2016-12-31 | $2.12B | $0.24B | 11.54% |
| 2016-09-30 | $2.00B | $0.22B | 10.76% |
| 2016-06-30 | $2.05B | $0.21B | 10.45% |
| 2016-03-31 | $2.08B | $0.21B | 10.12% |
| 2015-12-31 | $2.11B | $0.21B | 9.93% |
| 2015-09-30 | $2.10B | $0.14B | 6.87% |
| 2015-06-30 | $2.07B | $0.13B | 6.17% |
| 2015-03-31 | $2.07B | $0.13B | 6.39% |
| 2014-12-31 | $2.07B | $0.12B | 5.99% |
| 2014-09-30 | $2.22B | $0.22B | 9.74% |
| 2014-06-30 | $2.20B | $0.21B | 9.74% |
| 2014-03-31 | $2.18B | $0.18B | 8.25% |
| 2013-12-31 | $2.16B | $0.16B | 7.60% |
| 2013-09-30 | $2.13B | $0.06B | 2.77% |
| 2013-06-30 | $2.12B | $0.04B | 2.08% |
| 2013-03-31 | $2.10B | $0.06B | 2.62% |
| 2012-12-31 | $2.11B | $0.06B | 2.61% |
| 2012-09-30 | $2.08B | $0.05B | 2.59% |
| 2012-06-30 | $2.03B | $0.06B | 2.72% |
| 2012-03-31 | $1.98B | $0.05B | 2.62% |
| 2011-12-31 | $1.92B | $0.06B | 3.34% |
| 2011-09-30 | $1.85B | $0.15B | 8.23% |
| 2011-06-30 | $1.81B | $0.16B | 8.55% |
| 2011-03-31 | $1.76B | $0.18B | 9.97% |
| 2010-12-31 | $1.70B | $0.17B | 9.75% |
| 2010-09-30 | $1.54B | $0.15B | 9.45% |
| 2010-06-30 | $1.49B | $0.13B | 8.51% |
| 2010-03-31 | $1.51B | $0.11B | 7.02% |
| 2009-12-31 | $1.55B | $0.10B | 6.39% |
| 2009-09-30 | $1.47B | $0.07B | 4.77% |
| 2009-06-30 | $1.57B | $0.09B | 5.74% |
| 2009-03-31 | $1.64B | $0.10B | 5.87% |
| 2008-12-31 | $1.66B | $0.10B | 6.27% |
| 2008-09-30 | $1.90B | $0.15B | 7.81% |
| 2008-06-30 | $1.85B | $0.15B | 8.20% |
| 2008-03-31 | $1.79B | $0.16B | 8.80% |
| 2007-12-31 | $1.73B | $0.15B | 8.62% |
| 2007-09-30 | $1.63B | $0.15B | 9.18% |
| 2007-06-30 | $1.59B | $0.15B | 9.21% |
| 2007-03-31 | $1.53B | $0.14B | 8.85% |
| 2006-12-31 | $1.48B | $0.14B | 9.75% |
| 2006-09-30 | $1.51B | $0.10B | 6.44% |
| 2006-06-30 | $1.48B | $0.10B | 6.42% |
| 2006-03-31 | $1.47B | $0.08B | 5.10% |
| 2005-12-31 | $1.47B | $0.07B | 4.55% |
| 2005-09-30 | $1.37B | $0.09B | 6.87% |
| 2005-06-30 | $1.35B | $0.08B | 6.14% |
| 2005-03-31 | $1.40B | $0.10B | 7.17% |
| 2004-12-31 | $1.43B | $0.10B | 6.92% |
| 2004-09-30 | $1.39B | $0.11B | 7.62% |
| 2004-06-30 | $1.42B | $0.10B | 7.35% |
| 2004-03-31 | $1.38B | $0.09B | 6.45% |
| 2003-12-31 | $1.34B | $0.07B | 5.51% |
| 2003-09-30 | $1.51B | $0.05B | 3.05% |
| 2003-06-30 | $1.51B | $0.04B | 2.39% |
| 2003-03-31 | $1.51B | $0.03B | 1.92% |
| 2002-12-31 | $1.50B | $-0.01B | -0.33% |
| 2002-09-30 | $1.62B | $-0.01B | -0.37% |
| 2002-06-30 | $1.60B | $0.03B | 1.88% |
| 2002-03-31 | $1.54B | $0.05B | 3.32% |
| 2001-12-31 | $1.53B | $0.10B | 6.62% |
| 2001-09-30 | $1.47B | $0.16B | 10.57% |
| 2001-06-30 | $1.46B | $0.10B | 7.13% |
| 2001-03-31 | $1.51B | $0.12B | 7.63% |
| 2000-12-31 | $1.57B | $0.12B | 7.69% |
| 2000-09-30 | $1.54B | $0.10B | 6.56% |
| 2000-06-30 | $1.59B | $0.10B | 5.99% |
| 2000-03-31 | $1.52B | $0.05B | 3.29% |
| 1999-12-31 | $1.36B | $0.05B | 3.30% |
| 1999-09-30 | $1.17B | $0.04B | 3.59% |
| 1999-06-30 | $0.97B | $0.08B | 7.71% |
| 1999-03-31 | $0.88B | $0.12B | 14.12% |
| 1998-12-31 | $0.99B | $0.16B | 15.74% |
| 1998-09-30 | $1.14B | $0.15B | 13.46% |
| 1998-06-30 | $1.31B | $0.15B | 11.53% |
| 1998-03-31 | $1.47B | $0.09B | 6.33% |
| 1997-12-31 | $1.46B | $0.05B | 3.63% |
| 1997-09-30 | $1.44B | $0.04B | 2.98% |
| 1997-06-30 | $1.44B | $0.04B | 2.98% |
| 1997-03-31 | $1.43B | $0.08B | 5.32% |
| 1996-12-31 | $1.43B | $0.08B | 5.60% |
| 1996-09-30 | $1.44B | $0.09B | 6.20% |
| 1996-06-30 | $1.44B | $0.09B | 6.10% |
| 1996-03-31 | $1.43B | $0.09B | 6.16% |
| 1995-12-31 | $1.42B | $0.09B | 5.99% |
| 1995-09-30 | $1.38B | $0.19B | 13.68% |
| 1995-06-30 | $1.36B | $0.11B | 8.11% |
| 1995-03-31 | $1.66B | $0.12B | 6.92% |
| 1994-12-31 | $2.00B | $0.12B | 6.10% |
| 1994-09-30 | $2.30B | $0.03B | 1.09% |
| 1994-06-30 | $2.71B | $0.11B | 3.99% |
| 1994-03-31 | $2.73B | $0.12B | 4.22% |
| 1993-12-31 | $2.70B | $0.12B | 4.52% |
| 1993-09-30 | $2.75B | $0.12B | 4.22% |
| 1993-06-30 | $2.75B | $0.12B | 4.47% |
| 1993-03-31 | $2.78B | $0.12B | 4.42% |
| 1992-12-31 | $2.79B | $0.12B | 4.34% |
| 1992-09-30 | $2.74B | $0.13B | 4.56% |
| 1992-06-30 | $2.74B | $0.13B | 4.60% |
| 1992-03-31 | $2.71B | $0.12B | 4.54% |
| 1991-12-31 | $2.69B | $0.12B | 4.46% |
| 1991-09-30 | $2.66B | $0.12B | 4.36% |
| 1991-06-30 | $2.60B | $0.11B | 4.22% |
| 1991-03-31 | $2.55B | $0.11B | 4.31% |
| 1990-12-31 | $2.47B | $0.11B | 4.32% |
| 1990-09-30 | $2.28B | $0.10B | 4.51% |
| 1990-06-30 | $2.02B | $0.10B | 4.95% |
| 1990-03-31 | $1.82B | $0.10B | 5.27% |
| 1989-12-31 | $1.65B | $0.10B | 6.00% |
| 1989-09-30 | $1.64B | $0.11B | 6.40% |
| 1989-06-30 | $1.56B | $0.10B | 6.49% |
| 1989-03-31 | $1.48B | $0.10B | 6.85% |
| 1988-12-31 | $1.41B | $0.10B | 6.90% |
| 1988-09-30 | $1.34B | $0.09B | 6.66% |
| 1988-06-30 | $1.32B | $0.09B | 6.84% |
| 1988-03-31 | $1.29B | $0.09B | 6.67% |
| 1987-12-31 | $1.27B | $0.09B | 6.72% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.261B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.474B | 25.66 |
| CVS Health (CVS) | United States | $117.307B | 11.70 |
| HCA Healthcare (HCA) | United States | $93.189B | 14.49 |
| Elevance Health (ELV) | United States | $89.472B | 14.04 |
| Cencora (COR) | United States | $60.778B | 18.57 |
| Natera (NTRA) | United States | $49.779B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.318B | 18.55 |
| Viatris (VTRS) | United States | $19.549B | 6.75 |
| Medpace Holdings (MEDP) | United States | $17.206B | 36.13 |
| DiDi Global (DIDIY) | China | $16.502B | 181.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.991B | 0.00 |
| Solventum (SOLV) | United States | $15.121B | 12.51 |
| ICON (ICLR) | Ireland | $13.318B | 18.10 |
| Charles River Laboratories (CRL) | United States | $13.052B | 27.62 |
| BrightSpring Health Services (BTSG) | United States | $11.666B | 40.11 |
| Avantor (AVTR) | United States | $10.558B | 19.04 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.972B | 78.36 |
| HealthEquity (HQY) | United States | $7.941B | 25.88 |
| Sonic Healthcare (SKHHY) | Australia | $6.793B | 0.00 |
| PACS (PACS) | United States | $6.761B | 22.72 |
| GETINGE (GNGBY) | Sweden | $6.602B | 18.65 |
| MiniMed (MMED) | United States | $6.302B | 0.00 |
| CochLear (CHEOY) | Australia | $6.298B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.100B | 23.07 |
| Sotera Health (SHC) | United States | $5.516B | 22.74 |
| Concentras Parent (CON) | United States | $4.638B | 22.87 |
| Organon (OGN) | United States | $3.590B | 4.56 |
| GeneDx Holdings (WGS) | United States | $2.905B | 270.61 |
| CareDx (CDNA) | United States | $2.770B | 315.00 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.123B | 12.44 |
| Establishment Labs Holdings (ESTA) | United States | $2.121B | 0.00 |
| Progyny (PGNY) | United States | $2.101B | 29.76 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.911B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.895B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.824B | 69.65 |
| Alignment Healthcare (ALHC) | United States | $1.807B | 45.84 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.692B | 10.16 |
| Freenome (FRNM) | United States | $1.583B | 0.00 |
| Ardent Health (ARDT) | United States | $1.512B | 8.65 |
| Agilon Health (AGL) | United States | $1.506B | 0.00 |
| Nutex Health (NUTX) | United States | $1.488B | 8.53 |
| InnovAge Holding (INNV) | United States | $1.481B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.210B | 247.00 |
| Teladoc Health (TDOC) | United States | $1.168B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.161B | 22.60 |
| CryoPort (CYRX) | United States | $0.836B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.701B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.462B | 0.00 |
| SBC Medicals (SBC) | United States | $0.461B | 9.53 |
| Forward Industries (FWDI) | United States | $0.444B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.387B | 5.62 |
| Shoulder Innovations (SI) | United States | $0.372B | 0.00 |
| Biodesix (BDSX) | United States | $0.301B | 0.00 |
| Embecta (EMBC) | United States | $0.291B | 2.51 |
| So-Young (SY) | China | $0.285B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.071B | 8.37 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |